PROVIDER PROFILE · NPI 1518981885

Barbara Martin

PRACTICECONVIVA MEDICAL CENTER MANAGEMENT LLCSee all providers at this practice →

Internal MedicineTamarac, FLI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,721

Beneficiaries

—

Total drug cost

$106K

Distinct drugs

Brand share

13.1%

Top prescribed drugs

Atorvastatin Calcium142 claims

Amlodipine Besylate139 claims

Metformin Hcl85 claims

Losartan Potassium79 claims

Levothyroxine Sodium64 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Barbara Martin's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 15 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · Tampa, FL	61	166
TAMARAC REHABILITATION & HEALTH CENTER INC	57	215
HORVATH, MARILYN	35	60
UNIVERSITY HOSPITAL, LTD.	34	100
VISTA CLINICAL DIAGNOSTICS LLC	33	186
VITAS HEALTHCARE CORPORATION OF FLORIDA	22	165
Gaston Mendez Diagnostic Radiology · Coral Springs, FL	22	82
Portable Medical Diagnostics Inc Portable X-Ray Supplier · West Palm Beach, FL	21	112
Elisabeth Nguyen Optometry · Sunrise, FL	20	33
SANCHEZ-TORRES, MODESTO	20	81
BAKER, SUZANNE	19	111
RICHTER, STANLEY	12	36

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history